The Lancet HIV in conversation with

Angela Colbers and Hylke Waalewijn on treatment for children with HIV

May 03, 2022 The Lancet HIV
The Lancet HIV in conversation with
Angela Colbers and Hylke Waalewijn on treatment for children with HIV
Show Notes

Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV.

Read the full article:
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv